Calcium Supplementation in Postmenopausal Women

PHASE3CompletedINTERVENTIONAL
Enrollment

374

Participants

Timeline

Start Date

January 10, 2004

Primary Completion Date

March 11, 2005

Study Completion Date

March 11, 2005

Conditions
Osteoporosis
Interventions
DRUG

PTH/Calcium

PTH(1-84) subcutaneous injection and calcium 700 mg oral

DRUG

PTH/placebo

PTH (1-84) injected subcutaneously and placebo provided orally

DRUG

placebo

Placebo injected subcutaneously and 700 mg calcium orally

Trial Locations (27)

19610

'Radiant Research, Wyomissing

20817

'Bethesda Health Research Center, Bethesda

31020

'Hospital Clinical del Parque, Chihuahua City

33461

'Radiant Research - Lake Worth, Lake Worth

37000

'Hospital Aranda de la Parra, León

44340

'OPD Hospital Civil de Guadalajara Dr. Juan I. Menchaca, Guadalajara

44650

'Hospital Civil de Belem, Guadalajara

44670

'Medica Monraz, Guadalajara

46202

'University Hospital & Outpatient Center, Indianapolis

48236

'Michigan Bone & Mineral Clinic, Detroit

52763

'Hospital Angeles de las Lomas, Huixquilucan

57201

'Brown Clinic, Watertown

57401

Odyssey Research/Avera United Clinic, Aberdeen

58103

Michael J. Lillestol, Fargo

58501

'Odyssey Research Services, Bismarck

58701

'Odyssey Research Services, Minot

60637

'The University of Chicago, Chicago

64040

'Hospital Universitario de Monterrey, Monterrey Nuevo Leon

68131

Creighton University School of Medicine, Omaha

69101

Odyssey Research, North Platte

79705

'Diabetes Center of the Southwest, Midland

83814

Odyssey Research/Bone Density of North Idaho, Coeur d'Alene

87106

'New Mexico Clinical Research and Osteoporosis Center, Albuquerque

91730

'Boling Clinical Trials, Rancho Cucamonga

C1012AAR

'IDIM, Buenos Aires

C1114AAI

'Centro de Osteopatias Medicas, Capital Federal

06700

'Instituto Mexicano de Investigacion Clinica, Mexico City

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Shire

INDUSTRY